Onconetix, Inc.
For the period ended Jun 30, 2026. Filed Aug 13, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 13, 2026
ONCO$3.58-48.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
The following documents are filed as exhibits to this Report.
EXHIBIT INDEX
| Incorporated by Reference | ||||
|---|---|---|---|---|
| Exhibit No. | Description | Form | Exhibit | Filing Date |
| 2.1 | Share Exchange Agreement, dated February 11, 2026, by and among Onconetix, Inc., Realbotix, LLC, Realbotix Corp, and Simulacra Corporation.† | 8-K | 2.1 | February 12, 2026 |
| 3.1 | Amended and Restated Certificate of Incorporation filed with Delaware Secretary of State dated February 23, 2022 | 8-K | 3.1 | February 24, 2022 |
| 3.2 | Certificate of Amendment to the Company’s Second Amended and Restated Certificate of Incorporation, dated April 24, 2023 | 8-K | 3.1 | April 24, 2023 |
| 3.3 | Certificate of Amendment to the Company’s Second Amended and Restated Certificate of Incorporation, dated December 21, 2023 | 8-K | 3.1 | December 21, 2023 |
| 3.4 | Certificate of Amendment to the Amended and Restated Certificate of Incorporation, as amended, of Onconetix, Inc., dated September 24, 2024 | 8-K | 3.1 | September 24, 2024 |
| 3.5 | Certificate of Amendment to the Amended and Restated Certificate of Incorporation, as amended, of Onconetix, Inc., dated June 11, 2025 | 8-K | 3.1 | June 11, 2025 |
| 3.6 | Certificate of Amendment to the Amended and Restated Certificate of Incorporation, as amended, of Onconetix, Inc. dated March 25, 2026 | 8-K | 3.1 | March 27, 2026 |
| 3.7 | Certificate of Amendment to the Amended and Restated Certificate of Incorporation, as amended, of Onconetix, Inc. dated May 20, 2026 | 8-K | 3.1 | May 19, 2026 |
| 3.8 | Fourth Amended and Restated Bylaws of the Company | 8-K | 3.2 | December 21, 2023 |
| 3.9 | Certification of Designation of Series C Preferred Stock. | 8-K | 3.1 | October 3, 2024 |
| 3.10 | Certificate of Correction to Certificate of Designations authorizing the issuance of the Series C Preferred Stock | 10-Q | 3.7 | June 12, 2025 |
| 3.11 | Certification of Designation of Series D Preferred Stock. | 8-K | 3.1 | September 26, 2025 |
| 3.12 | Certification of Designation of Series F Preferred Stock. | 8-K | 3.1 | July 29, 2026 |
| 4.1 | Form of Inducement PIO | 8-K | 4.1 | July 11, 2024 |
| 4.2 | Form of Warrant (Series C) | 8-K | 4.1 | October 3, 2024 |
| 4.3 | Form of Warrant (Series D) | 8-K | 4.1 | September 26, 2025 |
| 4.4 | Form of Warrant (Series E) | 8-K | 4.1 | October 3, 2025 |
| 10.1 | Common Stock Purchase Agreement, between the Company and the July 2026 ELOC Investor, dated July 28, 2026 | 8-K | 10.3 | July 29, 2026 |
| 10.2 | Registration Rights Agreement, between the Company and the July 2026 ELOC Investor, dated July 28, 2026 | 8-K | 10.4 | July 29, 2026 |
| 31.1* | Certification of Principal Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |||
| 31.2* | Certification of the Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |||
| 32.1** | Certification of the Principal Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |||
| 32.2** | Certification of the Principal Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |||
| 101.INS* | Inline XBRL Instance Document. | |||
| 101.SCH* | Inline XBRL Taxonomy Extension Schema Document. | |||
| 101.CAL* | Inline XBRL Taxonomy Extension Calculation Linkbase Document. | |||
| 101.DEF* | Inline XBRL Taxonomy Extension Definition Linkbase Document. | |||
| 101.LAB* | Inline XBRL Taxonomy Extension Label Linkbase Document. | |||
| 101.PRE* | Inline XBRL Taxonomy Extension Presentation Linkbase Document. | |||
| 104* | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). | |||
| * | Filed herewith. |
|---|
| ** | Furnished herewith. |
|---|
| † | Certain of the exhibits and schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601(a)(5). The Company agrees to furnish a copy of all omitted exhibits and schedules to the SEC upon its request. |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.